[
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−2",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−2",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−3",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−3",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−4",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−4",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−5",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−5",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−12",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−12",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−14",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−14",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−15",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−15",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of a VL encoded by one or more of the polynucleotides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof, or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−2",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−2",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−3",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−3",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−4",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−4",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−5",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−5",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−11",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−12",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−12",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−14",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−14",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "5×10−15",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    },
    {
        "molecule_name": "antibody or antigen-binding fragment",
        "protein_target_name": "DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide",
        "binding_metric": "Kd",
        "value": "10−15",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, an antibody or antigen-binding fragment thereof comprising, consisting essentially of, or consisting of one or more of the VH polypeptides described above specifically or preferentially binds to a DR6 polypeptide or fragment thereof; or a DR6 variant polypeptide, with an affinity characterized by a dissociation constant (K<sub>D</sub>) no greater than 5×10<sup>−2 </sup>M, 10<sup>−2 </sup>M, 5×10<sup>−3 </sup>M, 10<sup>−3 </sup>M, 5×10<sup>−4 </sup>M, 10<sup>−4 </sup>M, 5×10<sup>−5 </sup>M, 10<sup>−5 </sup>M, 5×10<sup>−6 </sup>M, 10<sup>−6 </sup>M, 5×10<sup>−7 </sup>M, 10<sup>−7 </sup>M, 5×10<sup>−8 </sup>M, 10<sup>−8 </sup>M, 5×10<sup>−9 </sup>M, 10<sup>−9 </sup>M, 5×10<sup>−10 </sup>M, 10<sup>−10 </sup>M, 5×10<sup>−11 </sup>M, 10<sup>−11 </sup>M, 5×10<sup>−12 </sup>M, 10<sup>−12 </sup>M, 5×10<sup>−13 </sup>M, 10<sup>−13 </sup>M, 5×10<sup>−14 </sup>M, 10<sup>−14 </sup>M, 5×10<sup>−15 </sup>M, or 10<sup>−15 </sup>M."
    }
]